Ryan J. Uitti, M.D.

Closed for Enrollment

• Implantable Neurostimulator for the Treatment of Parkinson's Disease (INTREPID) Jacksonville, Fla.

  The purpose of this study is to evaluate the safety and effectiveness of Boston Scientific's Vercise Deep Brain Stimulation (DBS) system in the treatment of patients with with advanced, levodopa-responsive bilateral Parkinson's disease (PD) which is not adequately controlled with medication.

• Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System (PROGRESS) Jacksonville, Fla.

  The purpose of this post market study is to support the chronic clinical performance of the Infinity Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG), DBS leads, extensions and related system components.

• Registry of Deep Brain Stimulation with the VERCISE™ System: Vercise™ DBS Registry Jacksonville, Fla.

  The purpose of this study is to document characteristics of real-world outcomes for Boston Scientific Corporation’s commercially approved Vercise™ System for Deep Brain Stimulation (DBS) when used according to the applicable Directions for Use.

• Tandem DBS for Parkinson's Disease: A Pilot Study Utilizing STN/GPi Hypothalamic Stimulation Jacksonville, Fla.

  Does dual hemispheric stimulation of the subthalamic nucleus (STN) and fornix/hypothalamus potentially improve cognitive function in patients with Parkinsons disease.